These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8437857)

  • 1. Leukemogenicity of v-myb-transformed monoblasts cells can be modulated by normal bone marrow environment.
    Bagnis C; Cosset FL; Samarut J; Moscovici G; Moscovici C
    Oncogene; 1993 Mar; 8(3):737-43. PubMed ID: 8437857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line.
    Bottazzi ME; Goodenow MM; Moscovici MG; Moscovici C
    Oncogene; 1993 Mar; 8(3):731-6. PubMed ID: 8437856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genes differentially expressed in two types of v-myb-transformed avian myelomonocytic cells.
    Nakano T; Graf T
    Oncogene; 1992 Mar; 7(3):527-34. PubMed ID: 1549365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicistronic retroviral vector reveals capacity of v-erbA to induce erythroleukemia and to co-operate with v-myb.
    Casini T; Graf T
    Oncogene; 1995 Sep; 11(6):1019-26. PubMed ID: 7566959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation by v-Myb.
    Lipsick JS; Wang DM
    Oncogene; 1999 May; 18(19):3047-55. PubMed ID: 10378700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein.
    Bartůnek P; Karafiát V; Dvoráková M; Záhorová V; Mandíková S; Zenke M; Dvorák M
    Oncogene; 1997 Dec; 15(24):2939-49. PubMed ID: 9416837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ex vivo model to study v-Myb-induced leukemogenicity.
    Dvorakova M; Kralova J; Karafiat V; Bartunek P; Dvorak M
    Blood Cells Mol Dis; 2001; 27(2):437-45. PubMed ID: 11259166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products.
    Merzak A; Soret J; Martinerie C; Sureau A; Crochet J; Perbal B
    Oncogene; 1992 Mar; 7(3):535-42. PubMed ID: 1549366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of chicken bone marrow cells by the v-ski oncogene.
    Larsen J; Meyer S; Steinlein P; Beug H; Hayman MJ
    Oncogene; 1993 Dec; 8(12):3221-8. PubMed ID: 7504231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages.
    Fu SL; Lipsick JS
    Cell Growth Differ; 1997 Jan; 8(1):35-45. PubMed ID: 8993832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts.
    Ondrousková E; Povolná K; Vána P; Benes P; Konecná H; Zdráhal Z; Smarda J
    Leuk Res; 2007 Feb; 31(2):221-9. PubMed ID: 16930693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc.
    al Moustafa AE; Quatannens B; Dieterlen-Lièvre F; Saule S
    Oncogene; 1992 Aug; 7(8):1667-70. PubMed ID: 1630827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v-Myb represses the transcription of Ets-2.
    Wang DM; Sevcikova S; Wen H; Roberts S; Lipsick JS
    Oncogene; 2007 Feb; 26(8):1238-44. PubMed ID: 16909100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene.
    Introna M; Golay J; Frampton J; Nakano T; Ness SA; Graf T
    Cell; 1990 Dec; 63(6):1289-97. PubMed ID: 2261644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian myeloblastic cell lines transformed by two nuclear oncoproteins, P135gag-myb-ets and p61/63myc: a model of retinoic acid-induced differentiation not abrogated by v-erbA.
    al Moustafa AE; Gautier R; Saule S; Dieterlen-Lièvre F; Cormier F
    Cell Growth Differ; 1994 Aug; 5(8):863-71. PubMed ID: 7986751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-myb oncogene and c-myb proto-oncogene expression in avian cells: morphological changes of the cells and topographic localization of myb proteins.
    Korb J; Stokrová J; Karafiát V; Dvoráková M; Cermáková V
    Acta Virol; 1996 Apr; 40(2):81-6. PubMed ID: 8886116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
    Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid.
    Benes P; Macecková V; Zatloukalová J; Kovárová L; Smardová J; Smarda J
    Leuk Res; 2007 Oct; 31(10):1421-31. PubMed ID: 17624428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.